tiprankstipranks
Trending News
More News >
Grand Brilliance Group Holdings Limited (HK:8372)
:8372
Hong Kong Market
Advertisement

Grand Brilliance Group Holdings Limited (8372) AI Stock Analysis

Compare
1 Followers

Top Page

HK:8372

Grand Brilliance Group Holdings Limited

(8372)

Rating:65Neutral
Price Target:
HK$0.00
▼(-100.00% Downside)
The overall stock score of 65 reflects strong financial performance with robust revenue growth and profitability, tempered by significant cash flow management challenges. The technical analysis indicates a bearish trend, which impacts the stock's attractiveness. Valuation metrics are reasonable, with a fair P/E ratio and a modest dividend yield, supporting the stock's overall score.

Grand Brilliance Group Holdings Limited (8372) vs. iShares MSCI Hong Kong ETF (EWH)

Grand Brilliance Group Holdings Limited Business Overview & Revenue Model

Company DescriptionGrand Brilliance Group Holdings Limited (8372) is a diversified holding company primarily engaged in the manufacturing and trading of quality consumer products. The company operates in various sectors including electronics, household goods, and health and beauty products, focusing on delivering innovative and high-quality solutions to its customers. With a strong commitment to sustainability and customer satisfaction, Grand Brilliance aims to expand its market presence both domestically and internationally.
How the Company Makes MoneyGrand Brilliance Group Holdings Limited generates revenue through multiple streams including direct sales of its consumer products, wholesale distribution to retailers, and e-commerce platforms. The company leverages strategic partnerships with suppliers and distributors to enhance its product offerings and market reach. Additionally, Grand Brilliance may engage in licensing agreements and collaborations with other brands to diversify its product range and increase revenue. The company's focus on quality and innovation helps to build customer loyalty, driving repeat sales and contributing to its overall earnings.

Grand Brilliance Group Holdings Limited Financial Statement Overview

Summary
Grand Brilliance Group Holdings Limited presents a solid financial position with strong equity ratios and minimal debt, indicating stability and financial flexibility. However, there are areas for improvement, particularly in cash flow generation and net profit margins, which have shown some pressure. The company's revenue growth and operational efficiency are commendable, though continued focus on margin improvement and cash flow management will be crucial for sustaining financial health and shareholder value.
Income Statement
75
Positive
The company demonstrates solid revenue growth with a Revenue Growth Rate of 6.78% from 2023 to 2024 and maintains a strong Gross Profit Margin of 51.20%. However, the Net Profit Margin has slightly decreased to 9.59% from the prior year's 9.86%, indicating some pressure on profitability. The EBIT Margin of 6.41% suggests operational efficiency, though it has declined from the previous year. Overall, the income statement shows stability with room for improvement in net profit margins.
Balance Sheet
82
Very Positive
The balance sheet is robust with a high Equity Ratio of 90.27%, indicating a strong equity base relative to total assets. The Debt-to-Equity Ratio is low at 0.01, reflecting minimal leverage and suggesting financial stability. Return on Equity is commendable at 7.60%, indicating effective use of equity to generate profits. The balance sheet reflects strong financial health with low debt levels and efficient equity utilization.
Cash Flow
68
Positive
The cash flow statement shows a decline in Operating Cash Flow from HK$12.66M to HK$6.72M, indicating reduced cash generation from operations. Free Cash Flow has also declined, though it remains positive at HK$4.91M. The Free Cash Flow to Net Income Ratio is 0.63, suggesting adequate, but declining, cash flow relative to net income. Despite these challenges, the company maintains positive free cash flow, which is a strength but highlights the need for improving operational cash generation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue82.29M94.45M81.90M76.70M71.98M70.24M
Gross Profit42.01M45.72M41.94M39.51M36.35M33.62M
EBITDA5.32M13.95M13.20M14.09M9.87M12.91M
Net Income8.45M9.46M7.86M7.56M4.05M7.86M
Balance Sheet
Total Assets116.13M132.19M114.50M115.25M110.32M112.01M
Cash, Cash Equivalents and Short-Term Investments66.48M60.96M60.47M61.86M55.74M70.26M
Total Debt4.20M3.91M1.43M4.45M4.48M4.87M
Total Liabilities11.50M20.75M11.22M16.58M16.82M18.96M
Stockholders Equity104.77M110.79M103.33M98.67M93.51M93.05M
Cash Flow
Free Cash Flow9.28M1.17M4.91M12.60M-4.12M5.62M
Operating Cash Flow10.11M1.35M6.72M12.66M-3.33M6.01M
Investing Cash Flow646.00K3.77M-395.00K-510.00K-3.96M-82.00K
Financing Cash Flow-5.67M-4.87M-7.42M-6.40M-7.58M-6.36M

Grand Brilliance Group Holdings Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.11
Price Trends
50DMA
0.12
Negative
100DMA
0.12
Negative
200DMA
0.10
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
42.71
Neutral
STOCH
22.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8372, the sentiment is Negative. The current price of 0.11 is below the 20-day moving average (MA) of 0.11, below the 50-day MA of 0.12, and above the 200-day MA of 0.10, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.71 is Neutral, neither overbought nor oversold. The STOCH value of 22.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8372.

Grand Brilliance Group Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
HK$89.60M9.498.84%2.23%15.32%20.41%
54
Neutral
HK$294.99M-305.54%-35.02%-64.05%
53
Neutral
HK$54.34M-9.43%-10.71%83.45%
51
Neutral
$7.85B-0.18-40.01%2.28%22.97%-2.05%
50
Neutral
HK$320.25M
-39.11%34.92%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8372
Grand Brilliance Group Holdings Limited
0.11
0.02
22.22%
HK:0673
China Health Group
0.60
-0.02
-3.23%
HK:0718
Tai United Holdings
0.06
0.04
200.00%
HK:0401
Wanjia Group Holdings Ltd.
0.10
0.05
100.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 26, 2025